← Leaderboards
Jihye Park
Dana-Farber Cancer Inst
$1,321,652
Attributed
$1,321,652
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $330.4K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,321,652 · 1
By mechanism
R50$1,321,652 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Steven P. Balk$19,509,335
- Himisha Beltran$8,786,271
- Dan Landau$24,446,517
- Donald W. Kufe$50,160,456
- Gordon J Harris$11,607,211
Others in their field
Other Rising Stars on “Androgen Antagonists”
- Remi Adelaiye-Ogala · State University Of New York At Buffalo$2,864,216
- Vadim Gurvich · University Of Minnesota$2,852,434
- Rajesh Krishnan · Oncternal Therapeutics, Inc.$1,810,779
- Justin Michael Drake · Astrin Biosciences, Inc.$1,732,079
- Cheuk Man Cherie Au · Arma Bio, Inc.$1,611,960
- Grinu Mathew · University Of Nebraska Medical Center$1,379,946
Research focus
Androgen AntagonistsAutomobile DrivingBiologicalBiologyBladderCancer GenomicsCancer ImmunotherapyCancer RiskCellsCellular StructuresChromatinCloud BasedCollaborationsCommunitiesComputing MethodologiesDisease ResistanceDrug DevelopmentDrug DiscoveryEpigenetic ProcessEvolutionFaceFundingGenetic TranscriptionAnalytical Tool
Grant awards (4)
Molecular origins and evolution to treatment resistance in genitourinary cancers$330,413
R50 · FY2025 · CA · contact PI
Molecular origins and evolution to treatment resistance in genitourinary cancers$330,413
R50 · FY2024 · CA · contact PI
Molecular origins and evolution to treatment resistance in genitourinary cancers$330,413
R50 · FY2023 · CA · contact PI
Molecular origins and evolution to treatment resistance in genitourinary cancers$330,413
R50 · FY2022 · CA · contact PI